More seniors means more home care.

Buy - Price 37.76 on July 28
by Jefferies & Co.

Shares of Amedisys, a home-nursing-services provider, are trading at a highly discounted 9.2 times our fiscal-year 2010 earnings-per-share estimate of $4.28. Given the current reform-driven overhang on home-nursing shares, we believe AMED should trade at a 20% discount to its normalized (historical) multiple of about 15 times price/earnings; hence, our 53 target. Once [health-care] reform is resolved, we expect AMED's multiple to expand to more appropriate levels. Market cap: $1 billion.

BARRON'S(Aug. 3) Buy
Shares of Amedisys, a home-nursing-services provider, is trading at a highly discounted 9.2 times our fiscal-year 2010 earnings-per-share estimate of $4.28. Given the current reform-driven overhang on home-nursing shares, we believe it should trade at a 20 discount to its normalized (historical) multiple of about 15 times PE; hence, our $53 target. Once health-care reform is resolved, we expect its multiple to expand to more appropriate levels.

15

PE of 16, and a PEG of 0.72.

From a recent Mad Money show: "This is a very controversial stock, it's a total battleground. It's too hard to me; I'm staying away."

Aging Baby boomer population

12.8

According to sources interviewed by CNBC's Bertha Coombs, Amedisys, Inc (AMED), Humana (HUM) and Stryker Corporation (SYK) appear poised to benefit significantly.

Top Five Fast-Growth Stocks
Brittany Umar details some of TheStreet.com Ratings prime picks.

Click here to watch the video.

Funny business going on?